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C-type lectin receptors (CLRs) that couple with the
kinase Syk are major pattern recognition receptors
for the activation of innate immunity and host
defense. CLRs recognize fungi and other forms of
microbial or sterile danger, and they induce inflam-
matory responses through the adaptor protein
Card9. The mechanisms relaying CLR proximal
signals to the core Card9 module are unknown.
Here we demonstrated that protein kinase C-d
(PKCd) was activated upon Dectin-1-Syk signaling,
mediated phosphorylation of Card9 at Thr231, and
was responsible for Card9-Bcl10 complex assembly
and canonical NF-kB control. Prkcd/ dendritic
cells, but not those lacking PKCa, PKCb, or PKCq,
were defective in innate responses to Dectin-1,
Dectin-2, or Mincle stimulation. Moreover, Candida
albicans-induced cytokine production was blocked
in Prkcd/ cells, and Prkcd/ mice were highly
susceptible to fungal infection. Thus, PKCd is an
essential link between Syk activation and Card9
signaling for CLR-mediated innate immunity and
host protection.
INTRODUCTION
The innate immune system uses germline-encoded pattern
recognition receptors (PRRs) to sense microbial pathogens or
other forms of danger, leading to the induction of inflammatory
responses and host defense (Medzhitov, 2009). Bona fide32 Immunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc.PRRs with signaling capacities that reprogram gene expression
include Toll-like receptors (TLRs), nucleotide-oligomerization
domain (Nod)-like receptors (NLRs), retinoic acid-inducible
gene-I (RIG-I)-like helicases (RLRs), and the recently emerging
family of spleen tyrosine kinase (Syk)-coupled C-type lectin
receptors (CLRs) (Kerrigan and Brown, 2011; Osorio and
Reis e Sousa, 2011). Central to the ability of these PRRs to elicit
inflammation and innate immunity is their capacity to activate the
canonical NF-kB signaling cascade (Vallabhapurapu and Karin,
2009).
Dectin-1, the first Syk-coupled CLR found to be crucial for
mammalian host protection, still serves as a paradigm for CLR
signaling (Brown and Gordon, 2001; Mo´csai et al., 2010; Taylor
et al., 2007). This receptor recognizes b-glucan carbohydrates
in the cell walls of fungi. Genetic studies in humans and mice
have revealed essential functions for Dectin-1 in antifungal
host protection (Ferwerda et al., 2009; Taylor et al., 2007). To
induce signaling, Dectin-1 contains an immunoreceptor tyro-
sine-based activation motif (ITAM)-like motif in its intracellular
tail, which is responsible for Syk engagement (Kerrigan and
Brown, 2011; Mo´csai et al., 2010). Additional Syk-coupled
CLRs with critical roles in antifungal immunity are Dectin-2 and
Mincle (Robinson et al., 2009; Saijo et al., 2010; Sato et al.,
2006; Wells et al., 2008), which associate with the ITAM-contain-
ing adaptor molecule Fc receptor g chain (FcRg) (Mo´csai et al.,
2010; Sato et al., 2006; Wells et al., 2008). Notably, ITAM-Syk-
coupled CLRs are not only involved in antifungal defense but
are also implicated in innate immunity to mycobacteria (Ishikawa
et al., 2009; Schoenen et al., 2010) or helminths (Ritter et al.,
2010), as well as in inflammatory responses triggered by viruses
or self-ligands (Chen et al., 2008; Kerrigan and Brown, 2011;
Osorio and Reis e Sousa, 2011; Sancho et al., 2009; Yamasaki
et al., 2008).
Figure 1. PKCd Is Tyrosine Phosphorylated upon
Dectin-1 Ligation
(A) BMDCs were left untreated (Ø) or stimulated for 10 min
with zymosan (Z). Cellular lysates were immunoblotted
with phospho-Tyrosine (p-Tyr) antibodies.
(B) BMDCs were stimulated with zymosan as in (A).
Proteins were immunopurified with p-Tyr antibodies or
IgG1 control (isotype) and visualized by Coomassie
staining after electrophoresis.
(C) BMDCs were left untreated or stimulated with zymosan
as in (A). Proteins from lysates were immunoprecipitated
with PKCd antibodies or isotype control and analyzed by
immunoblot with p-Tyr or PKCd antibodies.
(D) Immunoblot analysis of BMDCs stimulated with
zymosan for various times and probed with antibodies
against phospho-PKCd (Tyr311) or b-actin.
(E) BMDCs were left untreated or preincubated with Syk
inhibitor R406 (0.5, 1, 2 mM), Src-kinase inhibitor PP2 (1.5,
3, 6 mM), or its inactive analog PP3 (1.5, 3, 6 mM) and
stimulated for 10 min with zymosan. Lysates were
analyzed by immunoblot with antibodies against phospho-
PKCd, PKCd, phospho-PLCg2, or PLCg2.
All results are representative of at least three independent
experiments.
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PKCd Controls CLR Signaling to NF-kBCLR signaling is initiated by receptor proximal Src family
kinases that phosphorylate ITAMs or ITAM-like structures,
resulting in Syk recruitment and activation (Kerrigan and
Brown, 2011; Mo´csai et al., 2010; Osorio and Reis e Sousa,
2011). Syk is then responsible for tyrosine phosphorylation
of signaling intermediates that trigger downstream pathways,
including mitogen-activated protein kinase (MAPK) and NF-kB
signaling (Mo´csai et al., 2010). A general mediator of CLR
function is the adaptor protein Card9, which controls canonical
IkB-kinase (IKK) and NF-kB activation (Gross et al., 2006; Hara
et al., 2007; Mo´csai et al., 2010) and which is required for
inflammatory responses induced by Dectin-1 (Gross et al.,
2006; Hara et al., 2007), Dectin-2 (Robinson et al., 2009),
and Mincle (Schoenen et al., 2010; Werninghaus et al., 2009;
Yamasaki et al., 2008). Consistent with the essential roles of
the Card9 pathway in host defense, mice or humans with
a genetic loss of Card9 function are immunodeficient and
highly susceptible to fungal infections (Glocker et al., 2009;
Gross et al., 2006). Still, even though the Syk-Card9 pathway
is nonredundant in innate immunity, the molecular mecha-
nisms that couple CLR proximal events to Card9 activation
are undefined.
Here we used a proteomic approach to search for intracellular
mediators of CLR-Syk function. With Dectin-1 signaling as
a model, we report that PKCd (encoded by Prkcd) is activated
upon CLR stimulation and specifically required to induce
Card9-Bcl10 complex assembly for TAK1 activation and canon-
ical NF-kB control. We found that Prkcd–/– dendritic cells are
defective in innate immune responses to CLR stimulation and
that Prkcd–/– mice are highly susceptible to fungal infection.
These results identify a fundamental mechanism for inflamma-
tory cell activation, with essential roles in CLR-mediated innate
immunity.RESULTS
Zymosan Stimulation Triggers Tyrosine
Phosphorylation of PKCd
To gain insights into the mechanisms of Dectin-1-Syk sig-
naling, we stimulated primary bone marrow-derived dendritic
cells (BMDCs) from mice with zymosan. Zymosan is a
fungal cell wall preparation composed primarily of b-glucans
and functions as a strong Dectin-1 agonist. In addition, it
contains ligands for Dectin-2 and TLR2 (Brown and Gordon,
2001; Gross et al., 2006; Robinson et al., 2009; Taylor et al.,
2007). As expected, zymosan stimulation induced tyrosine
phosphorylation of multiple target proteins (Figure 1A). To
reveal the identity of these molecules in an unbiased manner,
we affinity purified the tyrosine-phosphorylated proteins and
analyzed these by mass spectrometry (MS) (Figure 1B). The
20 specifically tyrosine-phosphorylated proteins with the high-
est Mascot scores included four kinases: the receptor proximal
Src family members Lyn and Fgr, together with Syk and PKCd
(data not shown). Because we were particularly interested
in putative Syk effector molecules, we focused our attention
on PKCd.
To validate zymosan-induced PKCd phosphorylation, we
immunoprecipitated this specific kinase from stimulated BMDCs
and subsequently performed immunoblots with phospho-tyro-
sine antibodies. Consistent with our MS data, zymosan treat-
ment induced strong PKCd tyrosine phosphorylation (Figure 1C).
Then, we performed analyses with a phosphospecific antibody
raised against PKCd tyrosine (Tyr) 311, a residue involved in
PKCd activation (Konishi et al., 2001). Robust, activation-specific
PKCd Tyr311 phosphorylation was rapidly detected in response
to zymosan treatment (Figure 1D). To test whether this PKCd
phosphorylation was mediated via Src and Syk signaling, weImmunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc. 33
Figure 2. Selectively Impaired Dectin-1 Signaling in Prkcd–/– BMDCs
(A) BMDCs were left untreated or preincubated with PKC inhibitor panPKC LMWI (5 mM) and stimulated with zymosan (20 mg ml1), curdlan (400 mg ml1), LPS
(200 ngml1), or CpG-DNA (2 mM) for 6 hr. TNF, IL-10, and IL-2 concentrations in the supernatants were assayed by ELISA. Data are expressed asmeans + SD of
triplicate samples.
(B) TNF production in Prkca/, Prkcb/, Prkcq/, or Prkcd/ BMDCs that were left untreated (Medium) or stimulated with zymosan (20 mg ml1), curdlan
(200 mg ml1), Pam3CSK4 (30 ng ml
1), or poly(I:C) (30 mg ml1) for 6 hr as indicated. Data are expressed as percent of WT + SD, derived from stimulations in
triplicates.
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PKCd Controls CLR Signaling to NF-kBpharmacologically blocked these receptor proximal tyrosine
kinases with the inhibitors PP2 or R406, respectively, before
stimulation of the cells. Both inhibitors impeded zymosan-
induced PKCd Tyr311 phosphorylation (Figure 1E). Thus, we
conclude from this first set of experiments that innate recognition
of zymosan activates PKCd through a Src and Syk tyrosine
kinase-dependent mechanism.
PKCd Is Essential for CLR-Mediated Cytokine
Production
Next, we were interested in the functional roles of PKCd in
Dectin-1-mediated innate immune responses. We therefore pre-
treated BMDCs with the selective PKC inhibitor panPKC LMWI
(Hermann-Kleiter et al., 2006) prior to stimulation. panPKC
LMWI inhibited TNF, IL-10, and IL-2 production in response to
zymosan stimulation or upon specific Dectin-1 triggering with
curdlan, a pure b-(1,3)-glucan polymer and selective agonist
for Dectin-1 (Figure 2A; LeibundGut-Landmann et al., 2007). In
contrast, treatment of the cells with panPKC LMWI did not inhibit34 Immunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc.cytokine secretion induced by TLR4 stimulation with LPS or
TLR9 stimulation with CpG-DNA (Figure 2A).
Because panPKC LMWI inhibits not only PKCd but also other
PKC isoforms (Hermann-Kleiter et al., 2006), we moved on to
a genetic approach to dissect the functions of individual PKCs
in CLR signaling. To this end, we generated BMDCs frommouse
strains that are deficient in either PKCa (encoded by Prkca)
(Leitges et al., 2002), PKCb (encoded by Prkcb) (Leitges et al.,
1996), PKCb and PKCq (encoded by Prkcq) (Pfeifhofer et al.,
2003), or PKCd (Leitges et al., 2001). Interestingly, BMDC differ-
entiation was not impaired by the lack of any of these PKC iso-
forms (data not shown). Moreover, BMDCs deficient in PKCa,
PKCb, or PKCb and PKCq produced regular amounts of TNF
and IL-10 in response to zymosan treatment or upon specific
Dectin-1 stimulation with curdlan (Figure 2B and data not
shown). In sharp contrast, Prkcd/ BMDCs were severely
impaired in zymosan- or curdlan-induced cytokine production,
although responses to TLR1-TLR2 stimulation with Pam3CSK4
or TLR3 triggering with long poly(I:C) were not reduced
Immunity
PKCd Controls CLR Signaling to NF-kB(Figure 2B). These findings indicate an essential and specific role
for PKCd in the Dectin-1 pathway. To characterize this function
in more detail, we performed dose-response experiments with
different PRR agonists. Again, we observed a critical require-
ment for PKCd in zymosan- or curdlan-mediated TNF and
IL-10 production, but cytokine production in response to TLR4
stimulation with LPS was not affected by the deletion of PKCd
(Figure 3A).
Because Dectin-1 signaling triggers not only the synthesis of
cytokines but also the phagocytosis of fungal components, as
well as the production of reactive oxygen species (ROS), we
studied the role of PKCd in these pathways. In contrast to cyto-
kine production, the phagocytosis of zymosan particles was
independent of PKCd, as assessed by either fluorescence
microscopy or flow cytometric quantification (Figures 3B and
3C). Moreover, the generation of ROS upon zymosan treatment
was not significantly impaired in Prkcd/ BMDCs (Figure 3D).
Next we investigated whether PKCd functions in Dectin-1-
independent CLR responses by stimulating Prkcd/ cells with
agonistic antibodies against Dectin-2 or with trehalose-6,6-di-
behenate (TDB), a synthetic adjuvant analog of the mycobacte-
rial cord factor that functions as a selective and specific agonist
for Mincle (Schoenen et al., 2010). Similar to the Dectin-1
responses, both Dectin-2- and Mincle-induced IL-10 and TNF
production were severely impaired in the absence of PKCd (Fig-
ure 3E and data not shown). These findings indicate that PKCd
plays a general role in Syk-coupled CLR response pathways,
where it is specifically required for the control of cytokine
synthesis.
PKCd Regulates Dectin-1-Mediated NF-kB Signaling via
Card9 Control
To define the molecular function of PKCd in CLR signaling, we
focused again on zymosan stimulation and selective Dectin-1
triggering (Figure 4). The overall tyrosine phosphorylation
pattern, the activation of Syk, as well as the phosphorylation of
the Dectin-1 signal transducer PLCg2 (Xu et al., 2009) did not
differ substantially between zymosan- or curdlan-stimulated
WT and Prkcd/ cells (Figure 4A and data not shown). More-
over, PKCd was to a large extent dispensable for Erk1 and
Erk2 MAPK activation, as shown by the fact that Erk1 and Erk2
phosphorylations were only slightly reduced in Prkcd/ cells
(Figure 4B). In sharp contrast, signaling to the canonical NF-kB
pathway, a key driver of cytokine production, was almost
completely blocked in zymosan-treated or Dectin-1-stimulated
Prkcd/ BMDCs, as indicated by the lack of phosphorylation
in the activation loops of IKKa and IKKb (Figure 4C).
As mentioned above, Dectin-1-Syk signaling engages the
Card9 adaptor protein for canonical IKK-dependent NF-kB acti-
vation (Gross et al., 2006; Mo´csai et al., 2010). To study the
potential involvement of PKCd in the Card9 signaling cascade,
we first stimulated Card9/ BMDCs (Gross et al., 2006) with
zymosan and investigated PKCd tyrosine phosphorylation.
PKCd was normally activated in the absence of Card9 (Fig-
ure 5A). Then, we tested the possibility that PKCd might directly
phosphorylate Card9. Indeed, in vitro kinase assays with re-
combinant proteins demonstrated that PKCd can phosphorylate
Card9 but not bovine serum albumin (Figure 5B). To search for
putative PKCd phosphorylation sites within Card9, we performeda bioinformatic analysis applying both the NetPhosK (http://
www.cbs.dtu.dk/services/NetPhosK/) and Scansite (http://
scansite.mit.edu/) target site prediction algorithms (Blom et al.,
2004; Obenauer et al., 2003). Three conserved PKC phosphory-
lation sites were predicted in both murine and human Card9.
These were Thr95, Thr231, and Ser303 (Figure 5C). Because
Thr95 and Thr231 are within the only two conserved TxK
or TxR motifs in Card9, we next performed immunoblot
analysis with proteins from the PKCd-Card9 kinase reaction
and a phosphoThreonine-x-Arginine (pTxR) antibody that recog-
nizes phosphorylated Thr followed by Arg or Lys at the +2
position. Consistent with the bioinformatic prediction, PKCd-
phosphorylated Card9 reacted with the pTxR antibody, indi-
cating phosphorylation at TxK motifs (Figure 5D). To further
map PKCd phosphorylation sites within Card9, we used site-
directed mutagenesis and transiently transfected expression
plasmids encoding tagged forms of WT-Card9, Card9(T95A),
Card9(T231A), or Card9(S303A) in HEK293 cells. We were tech-
nically unable to efficiently express the Card9(T95A) version in
mammalian cells, possibly because of effects of this mutation
on protein stability. Nevertheless, WT-Card9, Card9(T231A),
and Card9(S303A) were equally expressed in HEK293 cells
(data not shown) and were used upon purifications as substrates
for in vitro PKCd kinase assays (Figure 5E). The quantification of
radio-phospho incorporation revealed that WT-Card9 and
Card9(S303A) were equally phosphorylated by PKCd in vitro. In
contrast, the phosphorylation of the Card9(T231A) mutant was
reduced by 50% compared to the WT, demonstrating that
PKCd phosphorylates Card9 at position Thr231 and presumably
on additional sites.
To study the functional relevance of the Card9 Thr231 phos-
phorylation in CLR signaling, we next generated retroviral
vectors that expressWT-Card9, Card9(T231A), or Card9(S303A)
to reconstitute Card9 gene-deficient BMDCs. Subsequently, we
stimulated the reconstituted cells with the Dectin-1 agonist
Curdlan and measured the production of IL-10 as a readout for
productive signaling (Figure 5F). Although the Card9(S303A)
mutant restored the signaling defect of Card9-deficient cells to
the same extent as WT-Card9, Card9(T231A) was unable to
rescue Dectin-1 signaling for cytokine production. Together
with the biochemical results above, these data indicate that
PKCd mediates Thr231 phosphorylation of Card9 and that this
phosphorylation is essential for Card9 function.
PKCd Activates TAK1 via Card9-Bcl10 Complex
Formation
Upon cellular stimulation, Card9 forms a signaling complex with
its effector protein Bcl10 leading to canonical IKK-dependent
NF-kB signaling (Gross et al., 2006; Mo´csai et al., 2010). To
investigate the requirement for PKCd in these events, we
analyzed Card9-Bcl10 complex assembly in Prkcd/ cells. To
this end, we immunoprecipitated Bcl10 from zymosan-stimu-
lated WT and Prkcd/ cells and studied its association with
Card9 by protein immunoblot. Card9-Bcl10 complexes assem-
bled only in zymosan-stimulated WT BMDCs but not in cells
lacking PKCd (Figure 6A), indicating an essential function for
PKCd activity in Card9-Bcl10 complex formation.
How the Card9-Bcl10 signalosome activates IKKs has not
been well defined. However, given that Bcl10 can utilize theImmunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc. 35
Figure 3. PKCd Deficiency Particularly Impairs CLR Signaling but Not Phagocytosis
(A) WT and Prkcd/ BMDCs were incubated with the indicated concentrations of zymosan, curdlan, or LPS. TNF and IL-10 concentrations in the supernatants
were assayed by ELISA. Data are expressed as means ± SD of triplicates.
(B) BMDCs from WT and Prkcd/ mice were incubated for 2 hr with FITC-zymosan particles (100 mg ml1). FITC-zymosan internalization was visualized by
fluorescence microscopy (scale bars represent 20 mm).
(C) BMDCs were incubated with FITC-zymosan as in (B) for the times indicated. The frequencies of CD11c+ cells containing zymosan-FITC particles were
quantified by FACS analysis.
(D) BMDCs fromWT and Prkcd/mice were incubated with Luminol and were left untreated (Medium) or stimulated with zymosan. Luminescence was assayed
for 60 min in 10 min intervals and relative light units (RLU) as a measure for ROS generation integrated over time. Results represent means + SD from three
independent experiments.
(E) WT and Prkcd/ BMDCs were stimulated through Dectin-1, Dectin-2, or Mincle with curdlan (20 mg ml1), plate-bound Dectin-2 antibody, or TDB
(100 mg ml1), respectively. IL-10 concentrations in the cell culture supernatants were quantified by ELISA. Data are expressed as percent of WT + SD, derived
from stimulations in triplicates.
All results are representative of at least three independent experiments.
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PKCd Controls CLR Signaling to NF-kBkinase TAK1 for T cell receptor-mediated NF-kB activation (Sun
et al., 2004), we speculated that TAK1 could also be activated
through the Card9-Bcl10 complex during innate immune36 Immunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc.response. To test this hypothesis, we stimulated BMDCs of the
different genotypes with zymosan and investigated TAK1 phos-
phorylation. Indeed, zymosan-induced TAK1 phosphorylation
Figure 4. PKCd Controls NF-kB Activation
(A) Regular Syk and PLCg2 activation in Prkcd/ cells.
BMDCs from WT or Prkcd/ mice were stimulated with
zymosan for the indicated times. Syk and PLCg2 activa-
tion was determined by immunoblot with phospho-Syk
or phospho-PLCg2 antibodies. Immunoblotting with Syk,
PLCg2, and b-actin antibodies indicate equal protein
loading.
(B) WT or Prkcd/ BMDCs were stimulated with zymosan
as indicated. Activation of the MAP kinases Erk1 and Erk2
was determined by immunoblot with phospho-Erk1/2
antibodies. Immunoblotting with Erk1/2 and b-actin anti-
bodies indicates equal protein loading.
(C) Defective NF-kB signaling in Prkcd/ BMDCs. Cells
were stimulated with zymosan or curdlan as indicated.
Lysates were analyzed by immunoblot with phospho-
PKCd, phospho IKKa/b and PKCd, IKKa, IKKb, and b-actin
antibodies.
Immunity
PKCd Controls CLR Signaling to NF-kBwas strictly dependent on Card9 (Figure 6B). Moreover and in
line with our finding that Prkcd/ BMDCs were defective in
Card9-Bcl10 activation, zymosan-induced TAK1 activation was
abrogated in PKCd-deficient cells (Figure 6C). To directly inves-
tigate the function of TAK1 in zymosan-induced NF-kB signaling,
we pretreated BMDCs with the selective chemical TAK1 inhibitor
(5Z)-7-Oxozeaenol before cell stimulation (Ninomiya-Tsuji et al.,
2003). Although TAK1 inhibition did not block zymosan-induced
PKCd activation, it prevented the activation of IKKs (Figure 6D).
Together, these findings indicate that PKCd plays an essential
role upstream of the Card9-Bcl10 module, which is critical for
the subsequent activation of TAK1 and the engagement of the
canonical NF-kB pathway.
PKCd Is Essential for Innate Antifungal ImmuneDefense
After uncovering the molecular functions of PKCd in CLR
signaling, we were interested in its role in a pathophysiologically
relevant setting. As a clinically important model pathogen we
chose C. albicans because its PAMPs are recognized by Dec-
tin-1 (Taylor et al., 2007), Dectin-2 (Robinson et al., 2009), and
Mincle (Wells et al., 2008) and they drive Syk- and Card9-medi-
ated innate immunity and host defense (Glocker et al., 2009;
Gross et al., 2006; LeibundGut-Landmann et al., 2007; Robinson
et al., 2009). Although C. albicans infection of WT BMDCs
induced a robust and dose-dependent production of cytokines,
TNF, IL-10, and IL-1b, production of these cytokines was almost
completely abolished in the absence of PKCd (Figure 7A). Also
on the biochemical level we observed that, in spite of normal
Syk phosphorylation, Prkcd/ BMDCs had severe deficiencies
in activating NF-kB signaling after stimulation with C. albicans
hyphae, a potent agonist of Dectin-2 (Saijo et al., 2010). In line
with our results above, Prkcd/ cells furthermore showed
defects in IKK activation, as well as in IkBa phosphorylation
and degradation (Figure 7B) after C. albicans recognition.Immunity 36Finally, to study the relevance of these find-
ings for host protection in vivo, we infected
Prkcd/ mice with C. albicans. Compared to
the wild-type, PKCd-deficient mice exhibited
significantly greater weight loss upon infection
(Figure 7C) and had much lower survivalrates (Figure 7D). In an independent set of experiments, we
sacrificed the animals 8 days after infection and assessed
intravital fungal growth. Consistent with an essential role for
PKCd in innate resistance in vivo, we observed massive
fungal infiltration in the kidneys of Prkcd/ mice by histopa-
thology (Figure 7E) and detected significantly higher titers of
C. albicans in the kidneys, livers, small intestines, and spleens
(Figure 7F).
DISCUSSION
Our results defined an essential role for PKCd in the activation of
CLR-mediated, Card9-dependent innate immune responses.
Our findings are in line with the established functions of CLRs
and Card9 in antifungal defense (Ferwerda et al., 2009; Glocker
et al., 2009; Gross et al., 2006; Saijo et al., 2010; Taylor et al.,
2007), and we showed an essential activity of PKCd in host resis-
tance in vivo.
The detection of fungal particles by Dectin-1 and the subse-
quent activation of Syk triggers various intracellular signaling
pathways (Kerrigan andBrown, 2011;Mo´csai et al., 2010; Osorio
and Reis e Sousa, 2011). We observed that the recognition of
zymosan elicits a Src- and Syk-dependent phosphorylation of
PKCd at Tyr311, indicating that PKCd activation occurs down-
stream of Syk. Moreover, Prkcd/ BMDCs showed impaired
Card9-Bcl10 complex assembly and NF-kB control in spite of
normal Syk activation, demonstrating that PKCd acts upstream
of Card9. Together, these findings indicate that PKCd operates
as a missing link between Syk signaling and Card9 complex
formation for the activation of innate immunity. As shown by
the fact that only Prkcd/ BMDCs but not cells lacking PKCa,
PKCb, or PKCq were defective in Dectin-1-induced cytokine
production, PKCd is the specific PKC isoform for signaling in
the Dectin-1 pathway., 32–42, January 27, 2012 ª2012 Elsevier Inc. 37
Figure 5. PKCd Mediates Card9 Phosphorylation for Cytokine Production
(A) Normal PKCd activation inCard9/ cells. BMDCs fromWT and Card9/mice were stimulated for 10 min with zymosan. PKCd activation was determined by
immunoblot with antibodies against phospho-PKCd, PKCd, or b-actin.
(B) In vitro kinase assay. Recombinant PKCd was incubated with recombinant Card9 or BSA and g-[32P]ATP for 60 min. Autophosphorylation of PKCd and
phosphorylation of Card9 was visualized by autoradiography.
(C) Alignment of highly conserved putative PKC phosphorylation sites within Card9. Basic amino acids are depicted in blue and acidic amino acids in red.
(D) Recombinant PKCd and/or recombinant Card9 was incubated with ATP for 2 hr. Card9 TxR-phosphorylation was determined by immunoblot with antibodies
against phospho-TxR, Card9, or PKCd.
(E) Strep-tagged WT-Card9, Card9(T231A), or Card9(S303A) were expressed in HEK293 cells, purified, and incubated in vitro with recombinant PKCd and
g-[32P]ATP. Left: phosphorylation of PKCd and Card9 mutants were analyzed by autoradiography. Equal Card9 loading was verified by Coomassie Brilliant
Blue (CBB) staining. Right: Card9 phosphorylation quantified by densitometry. Results represent means + SD from three independent experiments.
(F) Card9-deficient BMDCs were retrovirally reconstituted with empty vector or vectors expressing WT-Card9, Card9(T231A), or Card9(S303A). Reconstituted
cells were stimulated with Curdlan and IL-10 concentrations in the supernatants were measured by ELISA. ND: not detectable. Results represent means + SD
from one experiment representative of three independent experiments.
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PKCd Controls CLR Signaling to NF-kBTreatment of the cells with a small molecule PKC kinase inhib-
itor blocked zymosan- or curdlan-induced cytokine production.
This indicates that the enzymatic serine-threonine kinase activity
and not merely a scaffold function of PKCd is responsible for
its activity in Dectin-1 signaling. In vitro kinase assays revealed
that Card9 is a direct PKCd substrate and that PKCd phosphor-
ylates Card9 at position Thr231. PKCd is likely to phosphorylate
other Card9 residues because the Card9(T231A) mutant was
still substantially phosphorylated by PKCd in vitro. Another
PKCd target site could be Thr95 because global proteomic
approaches have demonstrated Card9 phosphorylation at
Thr95 in vivo (Choudhary et al., 2009). Because we were unable
to express the Card9(T95A) mutant in mammalian cells, we were
not able to determine the physiological function of Thr95 phos-
phorylation but speculate that it might be important for protein
stability. Nevertheless, our genetic experiments with Card9-defi-
cient cells that were reconstituted with the phosphorylation-
defective Card9(T231A) mutant revealed that the Thr231 residue38 Immunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc.phosphorylated by PKCd is absolutely required for downstream
signaling and cytokine production. In addition, we observed that
PKCd signaling is essential for Card9-Bcl10 complex assembly
and for Card9-dependent TAK1 activation. Thus, we postulate
a molecular model in which Syk-induced PKCd activity mediates
direct Card9 phosphorylation, finally resulting in Card9-Bcl10
complex assembly for TAK1 activation. TAK1 then most prob-
ably mediates Dectin-1-induced IKK activation in a fashion
similar to its mode of triggering NF-kB activity in response to
stimuli from other immune receptors, such as TLRs (Vallabha-
purapu and Karin, 2009). This would be consistent with the
fact that pharmacological TAK1 blockage inhibited zymosan-
induced IKK activation.
Intriguingly, although the Card9 signaling pathway was
severely defective in Prkcd/ BMDCs, the phagocytosis of
zymosan and the production of ROS were largely intact and the
activationof ErkMAPKsignalingwasonly slightly reduced. These
findings indicate that PKCd controls only specific subsets of the
Figure 6. PKCd Triggers Card9-Dependent TAK1
Activation
(A) PKCd controls Card9-Bcl10 complex assembly. WT
and Prkcd/ BMDCs were stimulated with zymosan for
the indicated times and lysates subjected to immunopre-
cipitation with Bcl10-specific antibodies. Immunoprecipi-
tates and total lysates were immunoblotted as indicated.
(B) Card9-dependent TAK1 activation. WT or Card9/
cells were stimulated with zymosan as indicated. Lysates
were immunoblotted with antibodies against phospho-
TAK1, TAK1, or b-actin.
(C) PKCd mediates TAK1 activation. BMDCs from WT or
Prkcd/ mice were stimulated as in (B). Lysates were
analyzed by immunoblot with antibodies against phospho-
TAK1, TAK1, or b-actin.
(D) TAK1 signaling is critical for IKK activation. WT BMDCs
were pretreated for 30 min with DMSO (control) or the
selective TAK1 inhibitor (5Z)-7-Oxozeaenol (2 mM) and
stimulated with zymosan. Lysates were analyzed by
protein immunoblotting for PKCd and IKK activation with
antibodies against p-PKCd, PKCd, p-IKKa/b, and IKKb.
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PKCd Controls CLR Signaling to NF-kBDectin-1 responses. Because Dectin-1 ligation can activate the
serine-threonine kinase Raf-1 through alternative mechanisms
(Gringhuis et al., 2009), it is possible that Raf-1 might be re-
sponsible for Dectin-1-triggered and PKCd-independent Erk
activation, consistent with the role of Raf-1 in activating MAPK
pathways in numerous settings (Galabova-Kovacs et al., 2006).
Interestingly,Prkcd/micewere similar toCard9/mice (Gross
et al., 2006) in being highly susceptible to fungal infections. The
specific PKCd-Card9 effector response downstream of CLRs is
therefore absolutely critical for host defense. Theaforementioned
pivotal functions of Dectin-1 and Card9 in human antifungal
immunity were recently demonstrated in genetic studies (Fer-
werda et al., 2009; Glocker et al., 2009). In the future it will thus
be important to investigate whether genetic defects in PKCd
might also cause human immunodeficiency syndromes.
Many of our experiments aimed at identifying the principle
mechanisms of CLR signaling utilized zymosan stimulation or
selective Dectin-1 triggering. Yet in the absence of PKCd, activa-
tion of the NF-kB pathway as well as cytokine production were
also severely impaired in response to whole C. albicans cells.
Recent studies have indicated thatC. albicans cells, and particu-
larly C. albicans hyphae, are potent activators of Dectin-2
signaling (Saijo et al., 2010). Presumably the hyphae in addition
also activate Mincle (Wells et al., 2008). Thus, we propose that
PKCd also couples signals from those CLRs to the Card9-
controlled NF-kB pathway. This hypothesis is in line with our
observation that Prkcd/ BMDCs were defective in cytokine
responses to selective agonists for Dectin-2 and Mincle, which
formally establishesPKCdasageneral integratorofCLR function.
We believe that our findings have implications beyond anti-
fungal immunity. Mincle and Dectin-1 detect ligands on myco-
bacteria (Ishikawa et al., 2009; Rothfuchs et al., 2007) and
Card9/mice are impaired in the Mincle-induced inflammatory
response to the mycobacterial cord factor (Schoenen et al.,
2010; Werninghaus et al., 2009). These animals also succumb
rapidly to aerosol lung infection with Mycobacterium tuber-
culosis (Dorhoi et al., 2010). In addition, Schistosoma mansoni
activates Dectin-2 and Card9 (Ritter et al., 2010) and viruses
such as the Dengue virus induce inflammatory responsesthrough the ITAM-coupled CLRClec5a (Chen et al., 2008). More-
over, Dectin-1 also binds to unknown endogenous structures on
T cells (Ariizumi et al., 2000), the Syk-coupled CLRClec9a recog-
nizes ligands that are exposed upon cellular necrosis (Sancho
et al., 2009), and Mincle triggers Card9-dependent inflammatory
responses upon binding to SAP130 from necrotic cells under
sterile conditions (Yamasaki et al., 2008). Together with our
results, these data imply that PKCd might also mediate innate
responses to bacteria, parasites, or viruses or could be involved
in immune responses to conditions of noninfectious cell injury.
These hypotheses need to be investigated.
Finally, CLR-triggered Card9 signaling not only regulates the
immediate innate antimicrobial responses but also couples
innate recognition to the activation of adaptive immunity (Kerri-
gan andBrown, 2011;Osorio andReis e Sousa, 2011). Triggering
of the Card9 pathway by Dectin-1, Dectin-2, or Mincle ligands
on antigen-presenting cells controls the synthesis of distinct
cytokines. This cytokine milieu instructs the development of
antigen-specific Th17 cell responses and additionally induces
Th1 cell immunity (LeibundGut-Landmann et al., 2007; Robinson
et al., 2009; Saijo et al., 2010;Werninghaus et al., 2009). Th17 cell
responses are often associated with autoimmunity and polymor-
phisms in Card9 are recurrently detected in human inflammatory
diseases (Pointon et al., 2010; Zhernakova et al., 2008). It will
therefore be important to test whether PKCd signaling in innate
cells couples to Th17 cell responses and whether aberrant
activity in CLR-induced PKCd-Card9 signaling contributes to
human inflammatory disease. In this context, PKCd is a drugable
target and PKC inhibitors are in clinical trials. Thus, our findings
raise the possibility of therapeutically manipulating CLR-medi-
ated Card9 signaling by targeting PKCd function.
EXPERIMENTAL PROCEDURES
Mice and C. albicans Infections
Prkca/, Prkcb/, Prkcq/, Prkcd/, and Card9/ mice have been
described (Gross et al., 2006; Leitges et al., 1996, 2001, 2002; Pfeifhofer
et al., 2003). Mice were infected with 1 3 104–5 3 104 colony-forming units
(c.f.u.) of C. albicans (strain SC5314) as described (Gross et al., 2006) and
monitored daily for health and survival, according to institutional guidelines.Immunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc. 39
Figure 7. PKCd Is Critical for Antifungal Host Defense
(A) BMDCs from WT and Prkcd/mice were incubated with increasing doses of live C. albicans hyphae. Concentrations of TNF, IL-10, and IL-1b in the culture
supernatants were determined 6 hr later. Results are means ± SD of triplicates.
(B) BMDCs were stimulated for the indicated times with C. albicans hyphae or for 30 min with 100 ng ml1 LPS. Lysates were analyzed by immunoblot with
antibodies against phospho-Syk, Syk, phospho-IKKa/b, IKKa, IKKb, phospho-IkBa, IkBa, or b-actin.
(C and D) WT (n = 9) and Prkcd/ (n = 8) mice were infected intravenously with 53 104 colony-forming units (c.f.u.) of C. albicans and monitored daily for weight
changes (C) and survival (D). Statistical analysis was performed by log-rank test (p < 0.0001).
(E) Kidney sections from C. albicans-infected WT and Prkcd/ mice were stained with H&E or PAS (scale bars represent 300 mm).
(F) Mice were infected intravenously with 13 104 c.f.u. of C. albicans. After 8 days, C. albicans titers were determined in the kidneys, the liver, the small intestine,
and the spleen.
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PKCd Controls CLR Signaling to NF-kBFor fungal burden determination, the organ homogenates were plated in dilu-
tions on Sabouraud agar. For histological analyses, kidney sections were
stained with hematoxylin and eosin or periodic acid-Schiff according to stan-
dard protocols.40 Immunity 36, 32–42, January 27, 2012 ª2012 Elsevier Inc.BMDC Culture and Cell Stimulation
BMDCs were derived from bone marrow as described (Gross et al.,
2006) and stimulated with zymosan (Sigma), curdlan (Wako), LPS, CpG,
Pam3CSK4, poly(I:C) (all from Invivogen), Dectin-2 monoclonal antibody
Immunity
PKCd Controls CLR Signaling to NF-kB(AbD Serotec), TDB (Avanti Polar Lipids), or C. albicans strain SC5314, as
indicated. Where indicated, cells were pretreated for 20 min with the Syk
inhibitor R406 (Rigel), the Src kinase inhibitor PP2 or its inactive analog PP3
(both Calbiochem), the PKC inhibitor panPKC LMWI (ALTANA Pharma,
Konstanz, Germany), or the TAK1 inhibitor (5Z)-7-Oxozeaenol (Calbiochem
Merck).
Purification and Identification of Tyrosine-Phosphorylated Proteins
2 3 108 BMDCs were stimulated for 10 min with zymosan (300 mg ml1) and
lysed in RIPA buffer. The lysates were then subjected to immunopurification
with 20 mg of either an antibody against phospho-tyrosine (P-Tyr-100) or
mouse IgG1 as an isotype control coupled to Protein A Sepharose. Immuno-
purified proteins were eluted with Phenylphosphate (100 mM) in PBS, concen-
trated by ultrafiltration, and separated by 1-D PAGE. Whole gel lanes were cut
into 23 slices. After protein digestion, MS-MS spectra of individual gel slices
were obtained with a liquid chromatography coupled LTQ-Orbitrap XL hybrid
mass spectrometer (Thermo Electron). Peak lists were searched against
NCBInr database with Mascot v.2.2.06 as a search engine and MudPIT for
protein scoring.
In Vitro Kinase Assays
Recombinant PKCd was purchased from Proqinase (Heidelberg) and in vitro
kinase assays were performed according to manufacturers’ instructions.
Recombinant Card9 as a substrate was purified from E. coli by standard
protocols. Alternatively, the indicated Card9 mutants containing a Strep-tag
were transiently transfected into HEK293 cells andwere purifiedwith Streptac-
tin-sepharose (IBA BioTAGnology). In brief, 70 ng PKCd were incubated with
2 mg BSA, 2 mg Card9 (E. coli), or 1 mg HEK293 expressed Card9-versions in
70 mM HEPES-NaOH (pH 7.5); 3 mM MgCl2; 3 mM MnCl2; 3 mM Na3VO4;
1.2 mM DTT; 50 mg ml1 PEG20.000; 100 nM ATP; 5 mCi g-[32P]ATP; and
1% (v/v) DMSO in 20 ml for the indicated times. Samples were boiled in
Laemmli buffer, separated by SDS-PAGE, and analyzed by autoradiography.
For quantification, densitometric phospho-band signals were normalized to
Coomassie Brilliant Blue stain intensities.
Retroviral Reconstitution of Card9-Deficient BMDCs
Retroviral particles were generated by transfection of Phoenix-E cells with
pMIG retroviral vectors expressing the indicated mutants of human Card9,
as previously described (Glocker et al., 2009). Bone marrow cells of Card9/
mice were retrovirally transduced on day 1 and 2 of BMDC differentiation.
Successful transduction was verified by FACS analysis of GFP expression
from the bicistronic pMIG retroviral vectors and protein immunoblot analysis
of Card9 expression, as previously described (Glocker et al., 2009).
Cytokine Production
Concentrations of TNF, IL-10, IL-2, and IL-1b secreted into cell culture super-
natants of untreated and stimulated cells were analyzed with plate-bound
ELISA-kits (ELISA Ready-SET-Go!, eBioscience or BD OptEIA, BD Biosci-
ences PharMingen) according to manufacturers’ recommendations.
Zymosan Phagocytosis
BMDCs were left untreated or incubated for 30, 120, or 180 min with FITC-
labeled zymosan particles (100 mg ml1, Molecular Probes). After washing,
cells were analyzed either by microscopy for FITC fluorescence or by flow
cytometry for CD11c expression and FITC fluorescence in the CD11c-positive
population with a FACSCanto II (BD Biosciences) and FlowJo Software (Tree
Star, Inc.) according to standard protocols. Fluorescently labeled antibodies
were from eBioscience.
Reactive Oxygen Species Measurements
2 3 105 BMDCs were plated in 100 ml culture medium without GM-CSF into
a 96-well luminometer plate (Nunc). For stimulation, 100 ml HBSS containing
100 mM Luminol and zymosan was added to each well. The luminensence
was measured for 1 hr in 10 min intervals at a Mithras LB940 according to
manufacturers’ instructions. As a measure for ROS generation, relative light
units (RLU) were integrated over time.Signal Transduction
Protein immunoblots were performed as described (Gross et al., 2006) with
primary antibodies against Syk, phospho-Syk (Tyr525/526), PLCg2, phos-
pho-PLCg2 (Tyr759), phospho-Tyrosine (P-Tyr-100), PKCd, phospho-PKCd
(Tyr311), phospho-IKKa/b (Ser176/180), p44/42 MAPK (Erk1/2), phospho-
p44/42 MAPK (Erk1/2) (Thr202/Tyr204), IkBa, phospho-IkBa (Ser32/36),
phospho-TxR, TAK1, phospho-TAK1 (Thr184/187), Bcl10 (all Cell Signaling
Technology), IKKb, IKKa (Upstate Millipore), Card9 (Santa Cruz Biotech-
nology), or b-actin (Sigma). For coimmunoprecipitation experiments, BMDCs
were stimulated with zymosan as indicated and lysed in NP-40-containing
buffer. Lysates were cleared by incubation with Protein G Sepharose (GE
Healthcare 4 Fast Flow) and then incubated with a Bcl10 antibody. Immune
complexes were precipitated with Protein G Sepharose and subjected to
protein immunoblotting as indicated.
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